The Rising Tide of HBOT As A Promising Intervention for Diabetes-Related Issues
HBOT As An Efficacious Treatment for Comorbidities Associated with Diabetes
In 2022, approximately 37 million people were living with diabetes in the U.S., with an estimated 7 to 8 million undiagnosed cases, directly affecting communities across the nation.
Diabetes can be effectively treated, but it can also cause severe health complications. Those complications can be further exacerbated by comorbidities such as peripheral artery disease and radiation therapy for cancer.
Lower extremity wounds and foot ulcers are especially prevalent in the diabetic population. An estimated 19-34% of diabetics will develop a foot ulcer in their lifetime, many of whom will face an amputation.
The numbers can seem overwhelming, but at CūtisCare, our dedicated team of physicians and healthcare professionals is laser-focused on providing CMS-approved treatments for patients struggling with diabetic foot wounds.
The best way to prevent and treat chronic diabetic foot ulcers is early treatment and engaging with a comprehensive team of wound care professionals. And these early treatment plans should always consider HBOT.
The overall physiologic effect of hyperbaric oxygen treatment in patients with diabetic foot ulcers is to reverse the physiologic impediments caused by hypoxemia.
The National Institutes of Health pointed this out in a recent article:
HBOT has been effectively used to manage diverse clinical pathologies, such as non-healing diabetic ulcers…[technical content removed for brevity]. In conclusion, HBOT reduced oxidative and pro-inflammatory mediators, and may participate in activating healing, angiogenesis, and vascular tone regulation by increasing the release of growth factors.
We couldn’t agree more with pundits at the NIH. Over the last decade, HBOT has emerged as a go-to, CMS-approved treatment for diabetic foot ulcers with diverse etiologies. And that’s good news for wound care teams of all scopes and sizes.
It’s National Diabetes Awareness Month again. And as 2023 draws to a close, patients struggling with chronic diabetic foot wounds have access to efficacious treatments, including HBOT.
Now that’s something we can all be proud of.
Could your hospital, practice, or clinic benefit from improved diabetic wound care capabilities with HBOT?
Our team is laser-focused and passionate about facilitating exceptional patient outcomes through flexible, economical, and innovative HBOT solutions. In a nutshell, we provide hospitals, research facilities, clinics, and private practices nationwide with the solutions and expertise to treat their patients’ chronic wound issues, including diabetic foot ulcers.
Early treatment with HBOT will help you and your wound care team achieve some game-changing results aimed at:
- Improving your patients’ quality of life
- Reducing infections and tissue necrosis
- Reducing amputation rates
Are you in the planning phase of establishing a comprehensive wound care center, or perhaps re-evaluating your current wound management practice or program?
Would you like to become a recognized wound care center of excellence?
Or do you just have some questions about wound care and Hyperbaric Medicine?
Either way, we’d love to share our 25 years of knowledge and experience with you. Get in touch with one of our HBOT thought leaders today.